Jupiter Asset Management Ltd. Buys 50,246 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Jupiter Asset Management Ltd. lifted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 56.4% during the fourth quarter, Holdings Channel.com reports. The firm owned 139,377 shares of the medical equipment provider’s stock after buying an additional 50,246 shares during the quarter. Intuitive Surgical accounts for 0.7% of Jupiter Asset Management Ltd.’s portfolio, making the stock its 27th biggest holding. Jupiter Asset Management Ltd.’s holdings in Intuitive Surgical were worth $72,749,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in the company. Truvestments Capital LLC lifted its holdings in shares of Intuitive Surgical by 25.2% during the fourth quarter. Truvestments Capital LLC now owns 1,847 shares of the medical equipment provider’s stock worth $964,000 after buying an additional 372 shares in the last quarter. SHEPHERD WEALTH MANAGEMENT Ltd LIABILITY Co acquired a new stake in Intuitive Surgical in the 4th quarter worth about $283,000. Farther Finance Advisors LLC boosted its holdings in Intuitive Surgical by 13.4% in the 4th quarter. Farther Finance Advisors LLC now owns 3,289 shares of the medical equipment provider’s stock valued at $1,717,000 after purchasing an additional 389 shares during the period. EverSource Wealth Advisors LLC increased its holdings in shares of Intuitive Surgical by 16.3% during the fourth quarter. EverSource Wealth Advisors LLC now owns 1,210 shares of the medical equipment provider’s stock worth $632,000 after purchasing an additional 170 shares during the period. Finally, Sequoia Financial Advisors LLC raised its position in shares of Intuitive Surgical by 12.4% in the fourth quarter. Sequoia Financial Advisors LLC now owns 8,560 shares of the medical equipment provider’s stock valued at $4,468,000 after buying an additional 942 shares in the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, CFO Jamie Samath sold 94 shares of the firm’s stock in a transaction on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total transaction of $53,684.34. Following the completion of the sale, the chief financial officer now directly owns 2,630 shares of the company’s stock, valued at $1,502,019.30. This trade represents a 3.45 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, SVP Mark Brosius sold 489 shares of the business’s stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $533.18, for a total transaction of $260,725.02. Following the completion of the transaction, the senior vice president now directly owns 2,091 shares in the company, valued at $1,114,879.38. This trade represents a 18.95 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 13,309 shares of company stock valued at $7,611,004. Corporate insiders own 0.90% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts recently commented on the company. BTIG Research raised their price target on Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research report on Tuesday, November 26th. Citigroup boosted their target price on shares of Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research report on Friday, January 24th. Stifel Nicolaus increased their price target on shares of Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a research report on Thursday, December 5th. Morgan Stanley upgraded Intuitive Surgical from an “equal weight” rating to an “overweight” rating and upped their target price for the stock from $522.00 to $650.00 in a research note on Monday, December 2nd. Finally, JPMorgan Chase & Co. lifted their price target on Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and sixteen have issued a buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $613.10.

Intuitive Surgical Price Performance

NASDAQ ISRG opened at $493.72 on Wednesday. The company has a fifty day moving average price of $569.91 and a 200-day moving average price of $531.84. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00. The firm has a market cap of $175.85 billion, a price-to-earnings ratio of 77.02, a PEG ratio of 5.85 and a beta of 1.43.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.